UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer

Oral oncology, 2017-06, Vol.69, p.38-45

2017

Volltextzugriff (PDF)

Phase 2a Study of Cetuximab and Dasatinib in Patients With Cetuximab-Resistant Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.930-930

2016

Volltextzugriff (PDF)

High Tumor Mutational Burden May Predict Improved Response to Immunotherapy in Head and Neck Cancer Patients

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e43-e43

2024

Volltextzugriff (PDF)

Enfortumab Vedotin (EV) in the Previously Treated Advanced Head and Neck Cancer (HNC) Cohort of EV-202

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e18-e18

2024

Volltextzugriff (PDF)

Lachnoclostridium and Immune Inflamed Gene Expression Signature Association in Head & Neck Cancers

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e37-e37

2022

Volltextzugriff (PDF)

Definitive and Salvage Stereotactic Body Radiation Therapy (SBRT) for Nonmelanoma Skin Cancer of the Head and Neck

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e736-e737

2024

Volltextzugriff (PDF)

Use of the 40-Gene Expression Profile (40-GEP) Test to Identify Immune Suppressed Patients with Brigham and Women's Hospital (BWH) T1-T2a Cutaneous Squamous Cell Carcinoma (cSCC) at Higher Risk of Metastasis: Implications for Adjuvant Radiation

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S179-S179

2024

Volltextzugriff (PDF)

Oral Cavity Squamous Cell Carcinomas in Patients with a History of Oral Lichen Planus: Frequency and Outcomes

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e573-e573

2023

Volltextzugriff (PDF)

1088MO A phase II study of neoadjuvant cemiplimab for stage II to IV cutaneous squamous cell carcinoma (CSCC): One-year follow-up

Annals of oncology, 2023-10, Vol.34, p.S655-S655

2023

Volltextzugriff (PDF)

Oral Cavity Carcinoma with Persistent or Rapidly Progressive Disease after Surgical Resection: Outcomes of Additional Therapy

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e752-e752

2024

Volltextzugriff (PDF)

Highly-Multiplex Detection and Quantitation of Plasma Cell-Free Human Papillomavirus-16 DNA in Oropharyngeal Carcinoma

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e357-e357

2024

Volltextzugriff (PDF)

Quality of Life (QOL) of Patients with Human Papillomavirus (HPV)-Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) in NRG-HN002

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S121-S122

2024

Volltextzugriff (PDF)

Incidence and Outcome of Non-Malignant Pharyngeal Ulceration Following Definitive (Chemo)Radiation in Oropharyngeal Squamous Cell Carcinoma (SCC)

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e800-e801

2024

Volltextzugriff (PDF)

Interim Futility Results of NRG-HN005, A Randomized, Phase II/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer Patients

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S2-S3

2024

Volltextzugriff (PDF)

Cellular Immune and Genomic Biomarkers in NRG-HN003, a Phase I Study Adding Pembrolizumab to Adjuvant Cisplatin and Radiation Therapy (CRT) in Pathologically High-Risk Head and Neck Cancer (HNSCC)

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S129-S130

2024

Volltextzugriff (PDF)

Outcomes of Stage I Single Node HPV Positive Oropharynx Cancer

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e730-e731

2024

Volltextzugriff (PDF)

1091P Neoadjuvant cemiplimab for stage II–IV cutaneous squamous cell carcinoma (CSCC): 2-year follow-up and biomarker analyses

Annals of oncology, 2024-09, Vol.35, p.S722-S722

2024

Volltextzugriff (PDF)

Outcomes of Patients with Adenosquamous Carcinoma of the Head and Neck after Definitive Treatment

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e288

2022

Volltextzugriff (PDF)

Predictors of Locoregional Failure in Resected Medullary Thyroid Cancer: Implications for Adjuvant Radiation

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e327

2022

Volltextzugriff (PDF)

Can Circulating Tumor DNA be Utilized as a Marker to Guide High-Risk Head and Neck Squamous Cell Patients Treatment?

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e33-e34

2024

Volltextzugriff (PDF)

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer with Exploratory Biomarker Correlatives

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e10-e11

2024

Volltextzugriff (PDF)

Observations on Carotid Artery Stenosis Following Neck Irradiation

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e50-e51

2024

Volltextzugriff (PDF)

Characteristics and Management of Post Treatment Pharyngeal Ulceration in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Definitive Radiation/Chemoradiation

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e54-e54

2024

Volltextzugriff (PDF)

789O Neoadjuvant cemiplimab in patients (pts) with stage II–IV (M0) cutaneous squamous cell carcinoma (CSCC): Primary analysis of a phase II study

Annals of oncology, 2022-09, Vol.33, p.S904-S905

2022

Volltextzugriff (PDF)

Outcomes Following Immunotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Single-Institution Experience

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e40-e40

2022

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(110)
Tagungsberichte
(2)

Sprache

Englisch
(110)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer

Phase 2a Study of Cetuximab and Dasatinib in Patients With Cetuximab-Resistant Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

High Tumor Mutational Burden May Predict Improved Response to Immunotherapy in Head and Neck Cancer Patients

Enfortumab Vedotin (EV) in the Previously Treated Advanced Head and Neck Cancer (HNC) Cohort of EV-202

Lachnoclostridium and Immune Inflamed Gene Expression Signature Association in Head & Neck Cancers

Definitive and Salvage Stereotactic Body Radiation Therapy (SBRT) for Nonmelanoma Skin Cancer of the Head and Neck

Use of the 40-Gene Expression Profile (40-GEP) Test to Identify Immune Suppressed Patients with Brigham and Women's Hospital (BWH) T1-T2a Cutaneous Squamous Cell Carcinoma (cSCC) at Higher Risk of Metastasis: Implications for Adjuvant Radiation

Oral Cavity Squamous Cell Carcinomas in Patients with a History of Oral Lichen Planus: Frequency and Outcomes

1088MO A phase II study of neoadjuvant cemiplimab for stage II to IV cutaneous squamous cell carcinoma (CSCC): One-year follow-up

Oral Cavity Carcinoma with Persistent or Rapidly Progressive Disease after Surgical Resection: Outcomes of Additional Therapy

Highly-Multiplex Detection and Quantitation of Plasma Cell-Free Human Papillomavirus-16 DNA in Oropharyngeal Carcinoma

Quality of Life (QOL) of Patients with Human Papillomavirus (HPV)-Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) in NRG-HN002

Incidence and Outcome of Non-Malignant Pharyngeal Ulceration Following Definitive (Chemo)Radiation in Oropharyngeal Squamous Cell Carcinoma (SCC)

Interim Futility Results of NRG-HN005, A Randomized, Phase II/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer Patients

Cellular Immune and Genomic Biomarkers in NRG-HN003, a Phase I Study Adding Pembrolizumab to Adjuvant Cisplatin and Radiation Therapy (CRT) in Pathologically High-Risk Head and Neck Cancer (HNSCC)

Outcomes of Stage I Single Node HPV Positive Oropharynx Cancer

1091P Neoadjuvant cemiplimab for stage II–IV cutaneous squamous cell carcinoma (CSCC): 2-year follow-up and biomarker analyses

Outcomes of Patients with Adenosquamous Carcinoma of the Head and Neck after Definitive Treatment

Predictors of Locoregional Failure in Resected Medullary Thyroid Cancer: Implications for Adjuvant Radiation

Can Circulating Tumor DNA be Utilized as a Marker to Guide High-Risk Head and Neck Squamous Cell Patients Treatment?

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer with Exploratory Biomarker Correlatives

Observations on Carotid Artery Stenosis Following Neck Irradiation

Characteristics and Management of Post Treatment Pharyngeal Ulceration in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Definitive Radiation/Chemoradiation

789O Neoadjuvant cemiplimab in patients (pts) with stage II–IV (M0) cutaneous squamous cell carcinoma (CSCC): Primary analysis of a phase II study

Outcomes Following Immunotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Single-Institution Experience

Suchergebnisse filtern